Menu
Search
|

Menu

Close
X

Zosano Pharma Corp ZSAN.OQ (NASDAQ Stock Exchange Capital Market)

3.78 USD
+0.00 (+0.00%)
As of 8:59 PM GMT
chart
Previous Close 3.78
Open 3.78
Volume 5,788
3m Avg Volume 24,738
Today’s High 3.79
Today’s Low 3.74
52 Week High 25.69
52 Week Low 3.30
Shares Outstanding (mil) 11.97
Market Capitalization (mil) 45.26
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, USD)
FY18
0
FY17
0
FY16
0
FY15
0
EPS (USD)
FY18
-4.911
FY17
-18.136
FY16
-44.070
FY15
-49.251
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
29.57
Price to Sales (TTM)
vs sector
--
15.43
Price to Book (MRQ)
vs sector
1.25
4.06
Price to Cash Flow (TTM)
vs sector
--
21.23
Total Debt to Equity (MRQ)
vs sector
9.98
14.84
LT Debt to Equity (MRQ)
vs sector
0.00
11.13
Return on Investment (TTM)
vs sector
-103.53
12.77
Return on Equity (TTM)
vs sector
-111.67
14.47

EXECUTIVE LEADERSHIP

John Walker
Chairman of the Board, President, Chief Executive Officer, Since 2017
Salary: --
Bonus: --
Gregory Kitchener
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, Since 2018
Salary: --
Bonus: --
Eric Scharin
Vice President - Technical Operations, Since 2015
Salary: --
Bonus: --
Thorsten von Stein
Chief Medical Officer, Since 2015
Salary: --
Bonus: --
Joseph Hagan
Director, Since 2015
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

34790 Ardentech Ct
FREMONT   CA   94555-3657

Phone: +1510.7451200

Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability. The Company's short-wear-time transdermal patch consists of an array of titanium microneedles that is coated with its formulation of an approved drug and attached to an adhesive patch. When the patch is applied with its hand-held applicator, the microneedles painlessly penetrate the skin, resulting in rapid dissolution and absorption of the drug coating through the capillary bed. Its product candidates include ZP-Triptan, ZP-Glucagon and ZP-PTH. ZP-PTH is a formulation of teriparatide, a synthetic form of parathyroid hormone. ZP-Glucagon is a formulation of glucagon.

SPONSORED STORIES